• Home
• About Us
• Events
• Editorials
• Recent Contributions
• CMReJournal

• CMR Short Reviews
  • The Concept of CMR

    Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.

    • Definition and History
    • The Obesity and Type 2 Diabetes Epidemics
    • Epidemiology
    • Intra-abdominal Adipose Tissue: the Culprit?
    • Intra-abdominal Obesity and Cardiometabolic Risk
  • Evaluating CMR

    Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).

    • Clinical Tools
    • Imaging Techniques
    • Assessing CVD Risk: Traditional Approaches
    • Metabolic Syndrome and Type 2 Diabetes/CVD Risk
    • Assessing Cardiometabolic Risk
  • Managing CMR

    Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.

    • Targeting Traditional CVD Risk Factors in Patients With Abdominal Obesity
    • Residual Cardiometabolic Risk of Treated Patients
    • Effects of Weight Loss on Adipose Tissue Distribution
    • Managing CMR in Abdominally Obese Patients
    • Preventing Type 2 Diabetes
• Documentation Centre
  •  Slides, videos and more
    • Slide Library
    • Expert Opinions
    • Webcasts
    • Key Publications
    • Image Base
    • Advanced Search

• Home
• About Us
• International Academic Board
• Christie Ballantyne

About Us

Christie Ballantyne

• 1Scientific Training (1 page)
• 2Current and Past Positions (1 page)
• 3Publications and Book Chapters (1 page)
• 4Awards and Distinctions (1 page)
• 5Professional Associations (1 page)
• 6Additional Information (1 page)

Additional Information

Page: 6 of 6

---

Patents

Invention entitled “Non-Human Animal Having Predefined Allele of Cellular Adhesion Gene,” Arthur L. Beaudet, Raymond Wilson, Allan Bradley, William E. O'Brien, James Sligh, Christie M. Ballantyne and Daniel Bullard; OTA 92-49 and 93-34

---

Page: 6 of 6

Print this document

• Christie Ballantyne

See this member in the flowchart

• Contact Us
• Site Map
• Links
• Our Partners
• Press Room
• Legal Notices

© 2012, International Chair on Cardiometabolic Risk